Credit score: Pixabay/CC0 Public Area
In February 2024, the U.S. Division of Well being and Human Companies Panel for the Use of Antiretroviral Brokers in Adults and Adolescents with HIV (ARV Pointers Panel), in collaboration with the American School of Cardiology (ACC), the American Coronary heart Affiliation (AHA), and the HIV Medication Affiliation (HIVMA), developed statin remedy suggestions for individuals with HIV (PWH).
These suggestions had been knowledgeable by the outcomes of the REPRIEVE (Randomized Trial to Stop Vascular Occasions in HIV) research. A abstract of the suggestions related to physicians is printed in Annals of Inner Medication.
PWH are extra in danger for a lot of aging-related ailments, together with atherosclerotic heart problems (ASCVD). The REPRIEVE research was a Section III, international, randomized managed trial of oral pitavastatin versus placebo for the prevention of ASCVD in PWH aged 40 to 75 years at low to intermediate threat based mostly on 10-year threat estimates.
In contrast with placebo, pitavastatin was related to a 36% discount in MACE. These findings knowledgeable the ARV panel to suggest moderate-intensity statin remedy as the first prevention amongst PWH aged 40 to 75 years with low to intermediate 10-year ASCVD threat.
The panel additionally strongly recommends initiating statin remedy amongst individuals with a 10-year ASCVD threat rating of 5% or greater.
For PWH with a 10-year ASCVD threat rating beneath 5%, the panel favored statin remedy but additionally beneficial that affected person–clinician threat discussions contemplate HIV-related components than can enhance ASCVD threat.
Amongst PWH youthful than 40 years, selections to provoke statin remedy ought to be individualized and based mostly on threat components and familial well being historical past. The panel recommends the usage of at the very least moderate-intensity statins, together with pitavastatin, 4 mg day by day; atorvastatin, 20 mg day by day; or rosuvastatin, 10 mg day by day.
The authors word that future analysis is required to higher perceive absolutely the threat for ASCVD and different nonischemic CVD manifestations in individuals with HIV.
Extra info:
Statin Remedy as Main Prevention for Individuals with HIV: Suggestions from the U.S. HHS Antiretroviral Therapy Pointers Panel, Annals of Inner Medication (2025). DOI: 10.7326/ANNALS-24-03564
Editorial: www.acpjournals.org/doi/10.7326/ANNALS-25-01463
Supplied by
American School of Physicians
Quotation:
Panel recommends statins for adults with HIV in danger for heart problems (2025, Might 26)
retrieved 26 Might 2025
from https://medicalxpress.com/information/2025-05-panel-statins-adults-hiv-cardiovascular.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
